February 25, 2022 Octave Presents Clinical Validation Results of its Multivariate Blood-based Multiple Sclerosis Disease Activity Biomarker Test at ACTRIMS Forum 2022 Read More
February 24, 2022 ACTRIMS 2022 | A multivariate proteomic assay for disease activity assessments in MS – VJ Neurology Read More
October 21, 2021 Female Founders: Melinda Thomas of Octave Bioscience On The Five Things You Need To Thrive and Succeed as a Woman Founder – Authority Magazine Read More
